A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution.

MLA

Panel, Mathieu, et al. “A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution.” The Journal of Pharmacology and Experimental Therapeutics, vol. 376, no. 3, Mar. 2021, pp. 348–57. EBSCOhost, https://doi.org/10.1124/jpet.120.000359.

APA

Panel, M., Ahmed-Belkacem, A., Ruiz, I., Guichou, J.-F., Pawlotsky, J.-M., Ghaleh, B., & Morin, D. (2021). A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution. The Journal of Pharmacology and Experimental Therapeutics, 376(3), 348–357. https://doi.org/10.1124/jpet.120.000359

Chicago

Panel, Mathieu, Abdelhakim Ahmed-Belkacem, Isaac Ruiz, Jean-François Guichou, Jean-Michel Pawlotsky, Bijan Ghaleh, and Didier Morin. 2021. “A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution.” The Journal of Pharmacology and Experimental Therapeutics 376 (3): 348–57. doi:10.1124/jpet.120.000359.